![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Genetic and Genomic Testing for Prostate Cancer: Beyond DNA Repair
Cameron Herberts, Alexander W. Wyatt, Paul L. Nguyen, et al.
American Society of Clinical Oncology Educational Book (2023), Iss. 43
Closed Access | Times Cited: 14
Cameron Herberts, Alexander W. Wyatt, Paul L. Nguyen, et al.
American Society of Clinical Oncology Educational Book (2023), Iss. 43
Closed Access | Times Cited: 14
Showing 14 citing articles:
Identifying proteomic risk factors for cancer using prospective and exome analyses of 1463 circulating proteins and risk of 19 cancers in the UK Biobank
Keren Papier, Joshua R. Atkins, Tammy Y. N. Tong, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Keren Papier, Joshua R. Atkins, Tammy Y. N. Tong, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline
Evan Y. Yu, R. Bryan Rumble, Neeraj Agarwal, et al.
Journal of Clinical Oncology (2025)
Closed Access
Evan Y. Yu, R. Bryan Rumble, Neeraj Agarwal, et al.
Journal of Clinical Oncology (2025)
Closed Access
Reviewing the progress of cancer research in the USA
Israel Osejie Okoduwa, Bankole Ibrahim Ashiwaju, Jane Osareme Ogugua, et al.
World Journal of Biology Pharmacy and Health Sciences (2024) Vol. 17, Iss. 2, pp. 068-079
Open Access | Times Cited: 5
Israel Osejie Okoduwa, Bankole Ibrahim Ashiwaju, Jane Osareme Ogugua, et al.
World Journal of Biology Pharmacy and Health Sciences (2024) Vol. 17, Iss. 2, pp. 068-079
Open Access | Times Cited: 5
Natural language processing pipeline to extract prostate cancer-related information from clinical notes
Hirotsugu Nakai, Garima Suman, Daniel A. Adamo, et al.
European Radiology (2024)
Closed Access | Times Cited: 2
Hirotsugu Nakai, Garima Suman, Daniel A. Adamo, et al.
European Radiology (2024)
Closed Access | Times Cited: 2
Treatment landscape and burden of disease in metastatic castration-resistant prostate cancer: systematic and structured literature reviews
Darren Leaning, Gagandeep Kaur, Alicia K. Morgans, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
Darren Leaning, Gagandeep Kaur, Alicia K. Morgans, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
Precision Medicine in Castration-Resistant Prostate Cancer: Advances, Challenges, and the Landscape of PARPi Therapy—A Narrative Review
G Dimitrov, Radoslav Mangaldzhiev, Chavdar Slavov, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2184-2184
Open Access | Times Cited: 1
G Dimitrov, Radoslav Mangaldzhiev, Chavdar Slavov, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2184-2184
Open Access | Times Cited: 1
Diagnostics and treatment of BRCA-associated cancers with olaparib — expert position statement
Artur Kowalik, Anita Chudecka-Głaz, Joanna Kufel-Grabowska, et al.
Oncology in Clinical Practice (2024) Vol. 20, Iss. 4, pp. 229-244
Open Access | Times Cited: 1
Artur Kowalik, Anita Chudecka-Głaz, Joanna Kufel-Grabowska, et al.
Oncology in Clinical Practice (2024) Vol. 20, Iss. 4, pp. 229-244
Open Access | Times Cited: 1
Identifying proteomic risk factors for cancer using prospective and exome analyses: 1,463 circulating proteins and risk of 19 cancers in the UK Biobank
Keren Papier, Joshua R. Atkins, Tammy Y. N. Tong, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Keren Papier, Joshua R. Atkins, Tammy Y. N. Tong, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Mutational spectrum of DNA damage and mismatch repair genes in prostate cancer
Fidelis Charles Bugoye, Rispah Torrorey-Sawe, Richard Biegon, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 2
Fidelis Charles Bugoye, Rispah Torrorey-Sawe, Richard Biegon, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 2
How far does a new horizon extend for rucaparib in metastatic prostate cancer?
Fatima Karzai, Ravi A. Madan, William D. Figg
Translational Cancer Research (2024) Vol. 13, Iss. 1, pp. 11-14
Open Access
Fatima Karzai, Ravi A. Madan, William D. Figg
Translational Cancer Research (2024) Vol. 13, Iss. 1, pp. 11-14
Open Access
Prostatic adenocarcinoma: molecular underpinnings and treatment-related options
Divyangi Paralkar, Amir Akbari, Manju Aron
Urologic Oncology Seminars and Original Investigations (2024) Vol. 42, Iss. 7, pp. 203-210
Closed Access
Divyangi Paralkar, Amir Akbari, Manju Aron
Urologic Oncology Seminars and Original Investigations (2024) Vol. 42, Iss. 7, pp. 203-210
Closed Access
Genetic profiling in radiotherapy: a comprehensive review
Dino Rubini, Federico Gagliardi, Vittorio Salvatore Menditti, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Dino Rubini, Federico Gagliardi, Vittorio Salvatore Menditti, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer
Jarey H. Wang, Matthew P. Deek, Adrianna A. Mendes, et al.
Radiotherapy and Oncology (2024) Vol. 202, pp. 110618-110618
Closed Access
Jarey H. Wang, Matthew P. Deek, Adrianna A. Mendes, et al.
Radiotherapy and Oncology (2024) Vol. 202, pp. 110618-110618
Closed Access
Patient Selection: What Tumors Should Be Treated Based on Grade, Size, Location, Genetics and Risk Category?
Fabian Falkenbach, Ardalan E. Ahmad, James S. Wysock, et al.
(2024), pp. 263-273
Closed Access
Fabian Falkenbach, Ardalan E. Ahmad, James S. Wysock, et al.
(2024), pp. 263-273
Closed Access